Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Cerdulatinib for the treatment of b-cell malignancies

Cerdulatinib for the treatment of b-cell malignancies

US Patent 12350269 · Granted Jul 8, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antisense oligonucleotides directed to huntingtin2025
Compositions for management of polycystic ovary syndrome2025
Cerdulatinib for treating myeloma2024
Substituted pyridines, pyridazines, pyrimidines, and 1,2,4-triazines as TYK2 inh2024
Compounds for the modulation of proprotein convertase subtilisin/kexin type 9 (P2024
Substituted pyridines and pyridazines as TYK2 inhibitors2024
Substituted pyridines, pyridazines, and pyrimidines as TYK2 inhibitors2024
Phenylalanine small organic compounds to directly modulate PCSK9 protein activit2024
Composition and methods of use of tetrahydroisoquinoline small molecules to bind2024
Compositions for managing chronic obstructive pulmonary disease2024
Phenylpiperazine proprotein convertase subtilisin/kexin type 9 (PCSK9) modulator2024
Compounds for binding proprotein convertase subtilisin/kexin type 92024